# Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI

> **NCT01336803** · PHASE2 · COMPLETED · sponsor: **Heike E Daldrup-Link** · enrollment: 32 (actual)

## Conditions studied

- Bone Cancer
- Chondrosarcoma
- Ewing's Sarcoma
- Osteosarcoma
- Rhabdomyosarcoma
- Bone Necrosis
- Bone Sarcoma
- Osteomyelitis

## Interventions

- **DRUG:** Feraheme
- **PROCEDURE:** Magnetic Resonance Imaging (MRI) scan

## Key facts

- **NCT ID:** NCT01336803
- **Lead sponsor:** Heike E Daldrup-Link
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2014-07
- **Final completion:** 2023-10
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01336803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01336803, "Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01336803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*